Form 4: Anna U. Loengard Reports Changes in Beneficial Ownership of Clover Health Investments Corp. Stock

Director Anna U. Loengard reports acquisition of restricted stock units and adjustments to indirect beneficial ownership of Clover Health Investments Corp. shares.

Summary

• On January 6, 2025, Anna U. Loengard, a director of Clover Health Investments Corp., reported changes in her beneficial ownership of the company's Class A Common Stock.
• She acquired 60,975 shares underlying time-based restricted stock units (RSUs), which will vest on the first anniversary of the grant date, contingent upon her continued service as a director.
• Loengard also adjusted her reported indirect beneficial interest, removing 20,000 shares previously held in her ex-spouse's IRA, as well as 1,300 and 1,500 shares held in her son's and daughter's custodial accounts, respectively.
• Following these transactions, Loengard directly owns 599,816 shares of Class A Common Stock and indirectly owns 15,600 shares through her son's IRA and 15,110 shares through her daughter's IRA.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs indicates confidence in the company's future, while the adjustments to indirect ownership are routine.

Positives

• The acquisition of RSUs demonstrates continued alignment of the director's interests with the company's long-term performance.

Future Outlook

The vesting of the RSUs is contingent upon the Reporting Person's continued service as a director through January 6, 2026.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The reported changes in beneficial ownership provide transparency to shareholders regarding insider transactions.

Key Dates